ArticleOncogene2023

Therapeutic targeting of FUBP3 phase separation by GATA2-AS1 inhibits malate-aspartate shuttle and neuroblastoma progression via modulating SUZ12 activity.

Xiaojing Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.